Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 9, 2011

Primary Completion Date

August 5, 2022

Study Completion Date

August 5, 2022

Conditions
Psychological Effects of Study Drug
Interventions
DRUG

Lactose (inactive placebo)

Placebo in an equivalent weight to midomafetamine HCl will be administered in identical appearing capsules during one of two experimental sessions. An equivalent to the initial and supplemental dose will exist.

DRUG

midomafetamine HCl

120 mg midomafetamine HCl will be administered in opaque capsules at the outside of one of two experimental sessions, and upon mutual agreement between the investigator and participant, 40 mg may be administered 1.5 to 2.5 hours later.

Trial Locations (3)

29464

Zen Therapeutic Solutions, Mt. Pleasant

80304

Aguazul Bluewater, Inc., Boulder

87508

Santa Fe MDMA Therapy Training, LLC, Santa Fe

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY

NCT01404754 - Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers | Biotech Hunter | Biotech Hunter